Edelman appoints new head of digital health
September 16, 2011Medical Communications appointment, medical communications
Edelman has appointed Dave Pinnington as head of digital health for Europe to lead the development of the PR firm’s …
Firstlight launches new health offering
September 16, 2011Medical Communications Firstlight, medical communications news
London-based PR agency Firstlight has set up a new healthcare arm and appointed Pat Pearson to lead it. He is …
Merck’s COPD drug rejected by NICE
September 15, 2011Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast
NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …
Designing clinical trials for the real world
September 15, 2011Research and Development clinical trials
A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …
Almirall promotes Alfredo Barón
September 15, 2011Sales and Marketing appointment, sales and marketing
Spanish pharma company Almirall has promoted Alfredo Barón to area director for Southern and Eastern Europe. He has been with the …
Fresh scrutiny for new diabetes drugs
September 15, 2011Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes
Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …
Daiichi Sankyo subsidiary gets FDA warning
September 15, 2011Daiichi Sankyo, FDA, Luitpold
Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …
Digital Pharma: Lilly plans social media expansion
September 14, 2011Medical Communications Digital Pharma blog, Facebook, lilly, social media, youtube
One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …
First Paediatric Use Marketing Authorisation Granted
September 14, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …
GSK-Merck back new developing world cancer charity
September 14, 2011Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer
GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …
Merck collaborates with China-based genomics specialist BGI
September 14, 2011Research and Development BGI, Merck & Co, biomarkers, genomics
Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …
FDA unveils changes to cancer drug review
September 14, 2011Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs
The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …
GSK-Amicus start late-stage trials of Fabry disease treatment
September 14, 2011Research and Development Amicus Therapeutics, Fabry disease, GSK
GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …
Novartis loses global development head to Gates Foundation
September 14, 2011Research and Development Bill and Melinda Gates Foundation, Novartis, appointment
Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …
Government bites the bullet over A&E closure
September 14, 2011NHS, NHS reform, hosptials
The government has backed the closure of the Accident and Emergency department at Chase Farm hospital in London, ending years …
The recast of the Restriction of Hazardous Substances (RoHS) Directive
September 13, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …
Victoza data shows promise for early setting
September 13, 2011Research and Development, Sales and Marketing Novo Nordisk, Victoza
New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …
Betting big on research in China
September 13, 2011Manufacturing and Production, Research and Development China, R&D
For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …
AM-Pharma appoints new chief executive
September 13, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …
Genzyme confirms further Fabrazyme delay
September 13, 2011Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news
Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
